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FOREWORD
WHO operationally defines contaminated sites (CS) 
as “Areas hosting or having hosted human activities 
which have produced or might produce environmental 
contamination of soil, surface or groundwater, air, food-
chain, resulting or being able to result in human health 
impacts” [1]. Given this definition, an area affected by a 
single chemical contamination of a single environmen-
tal matrix (e.g., the soil contamination caused by a given 
pesticide), and a large area with soil, water, air, and food 
chain contamination by multiple chemicals (e.g., the 
contamination caused by long-term emissions of a pet-
rochemical complex) can both be considered as a CS. 
Among CS, Industrially contaminated sites (ICS) are 
of high concern from an environmental public health 
perspective, since industrial plants may produce a wide-
spread contamination that can result in several health 
impacts on the populations living in their neighbour-
hood. The assessment of the possible health impacts of 
ICS is challenging mainly due to the large extent of the 
affected contaminated areas, the coexistence of numer-
ous toxic substances and the concurrence of several res-
idential and/or occupational exposure pathways, with 
highly variable time and space patterns. Associated 
health effects can be acute or chronic, severe or mild, 
specific or, more often, non-specific.
The methodology and practices in studying ICS and 
health are very heterogeneous, and this is not surpris-
ing given their complexity in environmental health and 
social issues. While some countries have acquired sub-
stantial experience in the field, many others have lim-
ited resources and less intensive research in ICS topics. 
The international scientific debate on CS and health 
has been limited to few initiatives, like some interna-
tional meetings organised by WHO [1]. 
In 2013, based on the activities carried out in the 
field of CS, the first WHO Collaborating Center on 
Environmental Health in Contaminated Sites was es-
tablished at the Italian National Institute of Health 
(Istituto Superiore di Sanità, ISS) (http://www.euro.
who.int/__data/assets/pdf_file/0003/186240/e96843e.
pdf?ua=1). 
In 2015, on the basis of available evidence and ex-
periences, and on expert consultations promoted by 
WHO, the COST Action “Industrially Contaminated 
Sites and Health Network” (ICSHNet) was launched 
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Abstract
Industrially contaminated sites (ICS) are of high concern from an environmental public 
health perspective, since industrial plants may produce a widespread contamination that 
can result in several health impacts on the populations living in their neighbourhood. The 
objective of this contribution is to briefly explore available options in studying the health 
impact of ICS, mainly referring to information provided by documents and activities 
developed by the WHO and the WHO Collaborating Center for Environmental  Health 
in Contaminated Sites. In current practice the health impact of ICS is evaluated using 
studies and assessments falling in two broad types of strategies: one based on epidemiol-
ogy and the other on risk assessment methods. In recent years, traditional approaches 
to assess relationships between environmental risks and health has been evolved consid-
ering the intricate nature between them and other factors. New developments should 
be explored in the context of ICS to find common strategies and tools to assess their 
impacts and to guide public health interventions.


















(COST Action IS1408: http://www.cost.eu/COST_Ac-
tions/isch/Actions/IS1408). The ICSHNet Action aims 
at establishing and consolidating a European Network 
of experts and relevant institutions, and developing a 
common framework for research and response with 
the production of information for decision makers who 
have to deal with ICS issues.
The objective of this contribution is to briefly explore 
available options in studying the health impact of ICS, 
mainly referring to information provided by documents 
and activities developed by the WHO and the WHO 
Collaborating Center for environmental health in con-
taminated sites. Distinct research initiatives have pro-
vided significant pieces of evidence on how character-
izing the health impact of ICS (see for example Mudu 
et al. 2014 [2]), but at present a clear-cut classification 
of approaches is not possible. In current practice the 
health impact of ICS is evaluated using studies and as-
sessments falling in two broad types of strategies: one 
based on epidemiology and the other on risk assessment 
methods [1, 3]. Loosely speaking, these two strategies 
correspond to using health outcomes or environmental 
exposures, respectively, as a point of departure for an 
investigation.
EPIDEMIOLOGICAL APPROACHES 
Epidemiological studies conducted in ICS can be 
grouped in three main categories according to their 
aim: 
1. description of the health profile of populations living 
in ICS, suggesting possible associations with local envi-
ronmental risk factors;
2. analysis of the associations between environmental 
exposures and health outcomes and their causal nature, 
in order to test specific a priori hypotheses; 
3. surveillance of the evolving pattern of the population 
health profile.
These three types of contributions are described in 
the following sections.
Description of health profile
Some epidemiological methods can be adopted as 
a first basis for describing a population health profile. 
At a typical first level, such methods use routinely col-
lected health data, broken down analysed at area or 
small area level. In these studies, each unit of study is 
identified as a population localized in a geographical 
area for which is possible to compute epidemiological 
indicators (i.e. both aggregated data on the population 
and on its health outcomes are available). These studies 
have the potential to be applied in several countries, 
given the relatively modest data requirements. They 
can be regarded as methods for a fist-level approach 
because usually they do not require an ad hoc collection 
of data. Their main aim is to describe the health profile 
of populations, possibly generating hypotheses on local 
environmental risks. 
There are several examples of such studies carried 
out in different sites using different outcomes as, for 
example, the one on hospital admissions near a large 
industrial area in France [4] or the cancer incidence 
study around a steel plant in the Netherlands, where 
hierarchical Bayesian models were applied [5], both 
published in a monographic issue on ICS [3].
Typically, these studies require short time and low 
costs – though their interpretation is difficult. A notable 
example of a first level epidemiological approach is the 
one of SENTIERI implemented in Italy. The SENT-
IERI approach was developed to describe the health 
profile of populations living in national priority CS [6] 
by an a priori selection of health endpoints for which 
there exists evidence of association with the kind of 
industrial activities present in each site. In SENTIERI 
approach, the health outcomes are previously identified 
using the results of a review of the epidemiological lit-
erature on the health effects of the potential polluting 
activities occurring in CSs (named chemical industry, 
petrochemical plants and refineries, steel plants, power 
plants, mines and/or quarries, harbour areas, asbestos 
or other mineral fibres, landfills, and incinerators). The 
health profile of populations living in CSs is therefore 
firstly analysed evaluating the risks from the health 
outcomes characterized by an a priori interest. Health 
statistics are subsequently produced by using routinely 
collected data (for example, mortality and hospital dis-
charge files and/or data from pathology registries, such 
as those on cancer and congenital malformations) and 
computing epidemiological indicators at area level. In 
SENTIERI approach, the selection of diseases on the 
basis of a priori evidence limits the typical biases of de-
scriptive studies involving data dredging and multiple 
testing, which produce a lot of results and invite post-
hoc interpretation. 
General limitations of using “descriptive health pro-
file approaches” are intrinsic to their “ecological epide-
miological nature”. In these studies, health outcomes 
are estimated at group level rather than at the indi-
vidual level and exposure to contaminants is attributed 
to each group using aggregate measures or qualitative 
indicators. Ecological associations can be difficult to in-
terpret because of their aggregate nature; the exposure 
indicators do not reflect individual level exposure due to 
within-group heterogeneity in exposure and this is also 
the case for other factors which have a causative role 
for the health outcomes of interest. The more specific is 
the nature of the analysed associations and the homo-
geneity of within-group exposure, the more reliable can 
be the inferences on results. In every case, results from 
such approaches should be considered qualitatively and 
as clues to be deepened with other studies. 
The usefulness of first level descriptive approaches in 
ICS depends also on the availability of data at an ag-
gregate level such as to allow to distinguish communi-
ties living in the immediate neighborhood of ICS and 
experimenting all the complex milieu of exposures from 
the industrial plants, from populations which do no ex-
periment such influences. 
Analysis of associations
Analytical epidemiological studies are based on study 
designs capable to examine hypothesized causal re-
lationships and to make causal inferences. In general 
terms, analytical studies use individual data both on 
exposure and on health outcomes. However, in envi-


















ronmental epidemiology and even more in epidemio-
logical studies in ICS, the observational context limits 
data availability and collection. The common scenario 
is that environmental exposures are available at group 
level and mixed study design, with individual data on 
health outcome and aggregate data on exposure and 
on other predictive factors, are applied to test specific 
hypotheses.  
When deciding for a given analytical epidemiologi-
cal study in a ICS, several possible aspects of both the 
contamination and the exposed population must be 
considered, including: the presence of multiple sources 
of contamination; mixtures of contaminants; the evo-
lution over time of contamination; the co-existence of 
different exposure pathways: soil, water, air, food-chain 
can be contaminated; the exposure routes and timing 
of exposure; the health outcomes of interests (and their 
characteristics in terms of etiology); the size of the pop-
ulation and of the exposed groups; the socioeconomic 
gradients and environmental justice issues; the co-exis-
tence of environmental and occupational exposures; the 
local demand and expectations.
An aspect of great importance in defining the study 
objectives is the time dimension − in particular, the 
latency time between exposure and different adverse 
health effects. In evaluating long-term effects, which 
typically characterize the health impact of long lasting 
contaminations, study designs capable of evaluating 
spatial differences, as ecological studies (especially at 
small-area level), cross-sectional studies (e.g., biomoni-
toring), cohort and case-control studies are more suit-
able. For short-term effects, which are not common in 
ICS scenarios, study designs capable of evaluating tem-
poral differences, as time series or case-crossover stud-
ies, and panel studies can be adopted.
The C8 Health Project, that examined the health 
consequences of a perfluorooctanoic acid (PFOA) re-
lease in air and in water bodies from a chemical plant, is 
a notable example of an approach that combines mul-
tiple study designs to verify hypotheses of local inter-
est, and also achieve results of general validity (www.
c8sciencepanel.org/publications.html) [7]. A panel of 
experts was established to evaluate if there was a “prob-
able link” between PFOA exposure and any human dis-
ease. A Report was prepared for each selected health 
outcome, including a summary of the evidence for an 
association with exposure to PFOA.
In the C8 Health Project, a series of complementary 
studies were designed and carried out. They encom-
pass assessments of environmental contamination and 
population exposures, including biomonitoring. A large 
range of epidemiological studies on the risk of a priori 
selected health outcomes (mortality, morbidity and 
cancer incidence and prevalence; birth outcomes, im-
mune, hematopoietic, liver, kidney and endocrine func-
tion) were analysed in the general population, as well 
as in vulnerable subgroups, like children, and among 
workers employed in the polluting plant. 
Information obtained carrying out such studies were 
useful both locally in defining priorities of interventions, 
and for general purposes in evaluating the health risk 
due to a given agent (PFOA). Even if the C8 Health 
Project is a very interesting reference case-study, it is 
also an exception because of the specificity of the con-
tamination (only one target chemical), while usually 
in ICS the contamination is from multiple chemicals. 
Also, economic resources are not often available to de-
ploy a complete suite of studies.
In studying environment and health associations in 
ICS, it can be useful to integrate epidemiological geo-
graphical or micro-geographical studies (small-area) 
which use data at the population aggregated level, with 
typical analytical studies which use data at the individu-
al level; an exemplary case of applying such approach is 
the one of the Taranto industrial area, a wide industrial-
ized area with a long lasting contamination from differ-
ent industrial plants, located close to an urban area [8]. 
An example of methods to verify associations be-
tween exposures from a given contamination source 
and health effects supposed to be associated to those 
exposures is the one called “funnel approach” [9]. This 
method progressively allows insights into the associa-
tion between exposure and health effects through dif-
ferent phases, gradually shifting the evaluation from 
the population, small-area level, to the individual level. 
The approach is also based on a progressive refining of 
exposure assessment. It starts with a small-area analy-
sis at the population level and ends with the individual 
human biomonitoring. It has been applied to verify the 
potential association between exposure to dioxin and 
the risk of non-Hodgkin’s lymphomas in areas affect-
ed by waste incinerators [9]. This approach is suitable 
when the source of contamination is well defined and 
specific, and the distribution of given pollutants can be 
estimated.  
Surveillance 
Epidemiological surveillance in the environmental 
health field can be defined as “the systematic and con-
tinuous collection, analysis, interpretation of results, 
and dissemination of information on health profiles of 
populations associated with environmental factors for 
the planning, implementation and evaluation of risk 
management interventions” (modified from Tacker et 
al. 1996 [10]). In the context of areas contaminated 
by industrial activities, the epidemiological surveillance 
can be useful, for example, to evaluate the effectiveness 
of a remedial intervention or the reduction of the con-
tamination and/or exposure, by analyzing the evolution 
of specific indicators over time.
To reach this aim the following methods can be ap-
plied: 1) a descriptive approach based on routinely 
collected data at area or small-area level; 2) analytical 
longitudinal studies such residential cohort studies; 3) 
cross sectional studies, as the one based on biomonitor-
ing, with repeated surveys along time.
The descriptive approach can be based on defining 
outcomes of a priori interest depending on the con-
tamination and the likely associated health effects; an 
example of such is the SENTIERI approach described 
above [6]. Cohort analytical epidemiological studies are 
generally applied for assessing a range of health out-
comes in a population that was a priori identified ac-
cording to suitable admissibility criteria. In the context 


















of ICS cohort studies are based on the recruitment of 
the population living in the contaminated area and fol-
lowed up in time for outcomes with known or suspected 
links with the contamination [11, 12]. Therefore, with 
cohort studies, target populations can be monitored 
over time for their health status so helping in verify-
ing the evolution of risks, for example as a consequence 
of remediation activities or public health interventions. 
Finally, cross sectional studies with repeated surveys 
over time can give the idea of the over time evolution 
of population exposure profiles or prevalence of health 
risk. Among cross-sectional studies, those of human 
biomonitoring have, for some pollutants (as for exam-
ple, lead), the potential of evaluating the internal dose 
of contaminants so integrating the contribution of dif-
ferent pathways and routes of exposure [13].
HUMAN HEALTH RISK ASSESSMENT 
APPROACHES AND TOOLS
Risk assessments carried out in CS are often based 
on a traditional risk assessment approach, i.e., a multi-
step procedure that leads to estimating the probability 
of the occurrence of disease as a function of exposure 
to one or more agents. It often includes a comparison 
of estimated potential exposure to a reference value – 
for example, a comparison between measured exposure 
levels and a tolerable dose established by toxicology. 
In some countries the institutions responsible for 
risk assessment of ICS are well identified and use stan-
dardised procedures and tools. For example, in the US, 
the Environmental Protection Agency (EPA) has devel-
oped a specific set of tools for risk assessment in ICSs, 
implemented in the frame of the US Federal Govern-
ment’s program to clean up the nation’s uncontrolled 
hazardous waste sites, called Superfund. Each Super-
fund site is unique in terms of the present contami-
nants and their potential health effects. Therefore, EPA 
conducts risk assessments on a site-by-site basis. The 
risk assessment estimates the current and possible fu-
ture risks if no remediation action is undertaken (http://
www.epa.gov/oswer/riskassessment/risk_superfund.
htm). Among the procedures applied by public insti-
tutions in evaluating the health impact of ICS, special 
mention should be given to the Public Health Assess-
ment (PHA), an approach developed by the US Agency 
for Toxic Substances and Disease Registry (ATSDR). 
ATSDR has been required by law to conduct public 
health assessments at each of the sites on the EPA Na-
tional Priorities List. The aim of these evaluations is 
to establish if people are being exposed to hazardous 
substances and, if so, whether that exposure is harmful 
and should be stopped or reduced. ATSDR considers 
the same environmental data as the EPA, but focuses 
more closely on site-specific exposure conditions, spe-
cific community health concerns, and any available 
health outcome data to provide a more comprehensive 
and qualitative evaluation of possible public health haz-
ards. The PHA procedure is designed to reach its objec-
tives by combining health risk assessment procedures 
with an epidemiological descriptive assessment (www.
atsdr.cdc.gov/hac/PHAManual/toc.html). In fact, PHA 
combines quantitative risk assessment procedures with 
an approach that also evaluates health outcome data, 
when available, to identify whether rates of disease or 
death are elevated in a site community, especially if the 
community expresses concern about a particular out-
come (e.g., cancer).
Many tools are available for risk assessment in CS 
on a single pollutant basis; they are sophisticated, well-
founded, mainly focused on specific exposure pathways 
associated with soil contamination or air pollution [1], 
and providing a series of defaults values and statistics 
as, for example, the European Exposure Factors (Expo-
Facts, http://expofacts.jrc.ec.europa.eu/). 
Over the years, many risk assessments in CS have fo-
cused on the measurement of the health impacts due 
to chemicals, individually, and through individual path-
ways. However, in the last years the science of risk as-
sessment has developed and has paid attention to the 
need to explore the intricate relationship between risk 
factors. In fact, the causal pathway leading to an ad-
verse health outcome does not necessarily result from 
the independent contribution of concurrent risks, but 
can involve interactions between agents such as chemi-
cals with other conditions, for example those related to 
the socioeconomic and cultural contexts in which envi-
ronmental risks take place [14-16]. New developments 
and frontiers in risk assessment consider the intricate 
relationships within environmental risks and between 
them and other factors; relationships which typically 
characterize the contexts of ICS. Examples of such 
developments are the multipollutant approach and the 
incorporation of nonchemical stressors in community-
based risk assessment [17, 18]. 
The multipollutant approach deals with the evalua-
tion of both the health effects of pollutant mixtures, as 
well as the effects of single pollutants in a multipollutant 
context as those typical of complex contaminated areas. 
Characterizing exposure to multipollutant mixtures re-
quires an advanced understanding of the sources of pol-
lutants, the chemical transformations and interactions 
between multiple pollutants, and information on the 
correlations in space and time between their individual 
concentrations. The most relevant consideration for risk 
assessment in a multipollutant context is how different 
mixtures contribute to the overall exposures of popula-
tions and to distinguish which mixtures or parts of mix-
tures are most closely associated with particular health 
outcomes [17].
Another important recent development is the com-
munity-based risk assessment, i.e., the examination of 
all stresses affecting a defined population or community, 
including both the complex milieu of chemicals to which 
the community is exposed and its specific vulnerabilities 
which depends, among the others, on the composition 
of the population in terms of vulnerable subgroups (e.g., 
children), the socioeconomic conditions, the prevalence 
of personal habits which contribute to risk (e.g., smok-
ing). Non-chemical stressors make up an important 
subset of community vulnerabilities that have the poten-
tial to either directly affect the health of individuals or 
modulate their response to chemical exposures. Strides 
have been made in developing methods for conducting 
a cumulative risk assessment for multiple chemicals, but 


















integrating non-chemical stressors – physical or psycho-
logical – represents a new challenge. Furthermore, the 
inclusion of nonchemical stressors in cumulative risk 
assessments may enable risk assessors to identify those 
segments of the population who are more susceptible or 
vulnerable to the effects of chemical stressors [18].
Recently, important research efforts have been in-
vested considering the complexity of environmental risk 
factor scenarios. In Europe the research projects INTA-
RESE (www.intarese.org) and HEIMTSA (http://www.
innovationseeds.eu/Virtual_Library/Results/HEIMT-
SA.kl) were set up integrating epidemiological models 
that provide an overall qualitative/quantitative assess-
ment of the impact on health of environmental stressors 
by taking into account multiple risk factors, combined 
exposure pathways and cumulative health outcomes. 
Notwithstanding these developments, the question of 
how to apportion causality between two or more inter-
acting factors remains unsolved [15]. In US the EPA 
developed the NexGen project to design the next gen-
eration of risk science. The NexGen approach gives 
strong emphasis on problem formulation to ensure that 
risk assessments are designed in a way that can sup-
port decision makers. It is based on three phases [19]; 
after establishing the risk science objectives in phase I, 
a scientific assessment of risk using the best available 
scientific tools and technologies is undertaken in phase 
II. Phase III involves the use of scientific evidence in 
risk management decision-making context, taking into 
account extra-scientific considerations such as eco-
nomic analysis, sociopolitical considerations, and pub-
lic perception of risk [19]. Regarding risk assessment, 
the NexGen framework expands the classical Red Book 
four step evaluation [20] to incorporate a population 
health approach, new directions in toxicity testing, and 
new risk assessment methodologies. All determinants of 
health and their combination are considered dividing 
them in three categories: biological and genetic, envi-
ronmental and occupational, and social and behavioral. 
Environmental determinants include contaminants in 
air, food, water, or soil, as well as the built environment, 
so considering the wide spectrum and complexity which 
is typically present in ICS. 
Both the recent innovative developments in EU and 
US promote decision guided and holistic approaches to 
risk science which seem to be very suitable to be specifi-
cally implemented for risk assessments in the complex 
scenarios of ICS. 
A potentially promising tool to be applied to ICS, 
involving integrated measures of population health, is 
represented by the of Environmental Burden of Disease 
(EBD) approach. The use of such methodology as com-
parative risk assessment is based on producing or (more 
frequently) gathering and compiling epidemiological 
evidence and dose-response functions and estimating 
the excess health risk associated with different exposure 
scenarios. Quantifications of EBD could therefore be a 
useful instrument for setting priorities in environmental 
health policies and research in ICS. A recent example 
of the use environmental burden of disease is the overall 
assessment of the health impact of nine environmental 
risk factors in six European countries (benzene, dioxins, 
secondhand smoke, formaldehyde, lead, traffic noise, 
ozone, particulate matter (PM2.5), and radon [21]).
DISCUSSION
Industrially contaminated sites are of high concern 
from an environmental public health perspective at 
local, regional and global scale. In Europe, industrial 
activities, including industrial waste disposal and treat-
ment, cause the majority of the overall contamination 
(http://eusoils.jrc.ec.europa.eu/ESDB_Archive/eusoils_
docs/other/EUR26376EN.pdf).
Several other aspects contribute to make ICS and 
health a relevant public health issue: industrial contam-
inations usually affect different environmental media 
and concern complex mixtures of chemicals of toxico-
logical importance; social, occupational, environmental 
and health issues are strongly interconnected in these 
areas. Disadvantaged people are found to live in many 
polluted areas, near industrial and waste dumping sites, 
with poor-quality housing and limited access to green 
space and to good quality health services [22, 23].
Health impact assessments in ICSs do exist, yet the 
overall impact of ICSs is still unknown, due to fragmen-
tation of objectives and methods, the lack of integrated 
evaluating approaches, and the large variety of contami-
nated areas. 
Several different approaches and tools are currently 
available. However, since most of them have been de-
veloped in specific contexts (urban areas), or to ad-
dress specific problems (e.g., air pollution, wastes, food 
chains), and given the high heterogeneity in type of ICS 
and in the data and resources availability, there is a need 
to identify appropriate tools and methodologies able to 
account for the complex mix of environmental, health 
and social issues in ICSs. It is therefore urgent to move 
forward using suitable and harmonized strategies. The 
ecosystems-enriched Drivers, Pressures, State, Expo-
sure, Effects, Actions or 'eDPSEEA' model, proposed 
by Reis et al [24], is a good example of a framework in 
which developing integrated approaches. Such model is 
driven by sustainable development goals. It is focused 
on promoting both the human health and well-
being (with emphasis on vulnerable population sub-
groups, like children, pregnant women, elderly peopl-
e, ethnic minorities, and workers), while safeguard-
ing ecosystems.
A promising tool possibly suitable for ICS is exempli-
fied by the Integrated Environmental and Health Im-
pact Assessment (IEHIA), a multidisciplinary instru-
ment that draws from many different disciplines, like 
public health, social and political sciences, environmen-
tal science, urban planning, epidemiology and statistics 
[15]. The possibility to estimate the EBD associated 
with living in ICSs, possibly accounting for socioeco-
nomic factors, is another promising tool, valuable also 
to compare the impact of different pollutants on diverse 
health outcomes, in heterogeneous industrial polluted 
areas.
The COST Action IS1408 has established a network 
of 30 countries, involving about 100 researchers and ex-
perts in environmental health topics related to ICS. The 
Action is expected to contribute to providing participat-


















ing countries with proper tools and harmonised meth-
odologies in characterising the health impacts of ICSs, 
by a) clarifying knowledge gaps and research priorities; 
b) supporting collection of relevant data and informa-
tion; c) stimulating development of harmonised meth-
odology; d) promoting collaborative research initiatives, 
and developing guidance and resources on risk and 
impact assessment, management and communication, 
training and mobility of young research across Europe. 
Interactions between the COST Action ICSHNet 
and the European Environment and Health Process 
lead by WHO are well developed. The Roadmap to the 
sixth Conference of European Ministries in the sectors 
of Health and Environment, identifies 8 major envi-
ronmental health themes: air, water, energy, chemicals, 
food, cities, climate change and disasters, and waste. 
The ICSHNet is likely to deal with several of these 
themes, for example by identifying the most informa-
tive assessments with reference to the best available 
policy options, creating the conditions for undertaking 
comparable Health Impact Assessments of ICSs, and 
helping to transfer scientific evidence into the policy 
making process.
Environmental health and social issues related to 
industrial contamination, including industrial wastes, 
must be addressed through an intersectoral approach 
if we want to protect the environment and the public 
health and maximise wellbeing and prosperity in such 
areas. Therefore, the strategies to assess the health di-
mension of living in ICS have to be seen as part of a 
social negotiation, where the legitimate needs and as-
pirations of residents, vulnerable groups, workers, and 
investors are taken into account, in a fair process.
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